Table of Content

1 Anti-Emetic Drug Market Overview
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Anti-Emetic Drug Segment by Application
1.3.1 Global Anti-Emetic Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2018-2034
1.4.2 Global Anti-Emetic Drug Sales 2018-2034
1.4.3 Global Anti-Emetic Drug Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Anti-Emetic Drug Market Competition by Manufacturers
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2018-2024)
2.4 Global Anti-Emetic Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Anti-Emetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Emetic Drug, Product Type & Application
2.7 Anti-Emetic Drug Market Competitive Situation and Trends
2.7.1 Anti-Emetic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
2.7.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Emetic Drug Retrospective Market Scenario by Region
3.1 Global Anti-Emetic Drug Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Anti-Emetic Drug Global Anti-Emetic Drug Sales by Region: 2018-2034
3.2.1 Global Anti-Emetic Drug Sales by Region: 2018-2024
3.2.2 Global Anti-Emetic Drug Sales by Region: 2024-2034
3.3 Global Anti-Emetic Drug Global Anti-Emetic Drug Revenue by Region: 2018-2034
3.3.1 Global Anti-Emetic Drug Revenue by Region: 2018-2024
3.3.2 Global Anti-Emetic Drug Revenue by Region: 2024-2034
3.4 North America Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 North America Anti-Emetic Drug Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Anti-Emetic Drug Sales by Country (2018-2034)
3.4.3 North America Anti-Emetic Drug Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.5.1 Europe Anti-Emetic Drug Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Anti-Emetic Drug Sales by Country (2018-2034)
3.5.3 Europe Anti-Emetic Drug Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Emetic Drug Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Anti-Emetic Drug Sales by Country (2018-2034)
3.6.3 Asia Pacific Anti-Emetic Drug Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Latin America Anti-Emetic Drug Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Anti-Emetic Drug Sales by Country (2018-2034)
3.7.3 Latin America Anti-Emetic Drug Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Emetic Drug Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Anti-Emetic Drug Sales by Country (2018-2034)
3.8.3 Middle East and Africa Anti-Emetic Drug Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Emetic Drug Sales by Type (2018-2034)
4.1.1 Global Anti-Emetic Drug Sales by Type (2018-2024)
4.1.2 Global Anti-Emetic Drug Sales by Type (2024-2034)
4.1.3 Global Anti-Emetic Drug Sales Market Share by Type (2018-2034)
4.2 Global Anti-Emetic Drug Revenue by Type (2018-2034)
4.2.1 Global Anti-Emetic Drug Revenue by Type (2018-2024)
4.2.2 Global Anti-Emetic Drug Revenue by Type (2024-2034)
4.2.3 Global Anti-Emetic Drug Revenue Market Share by Type (2018-2034)
4.3 Global Anti-Emetic Drug Price by Type (2018-2034)
5 Segment by Application
5.1 Global Anti-Emetic Drug Sales by Application (2018-2034)
5.1.1 Global Anti-Emetic Drug Sales by Application (2018-2024)
5.1.2 Global Anti-Emetic Drug Sales by Application (2024-2034)
5.1.3 Global Anti-Emetic Drug Sales Market Share by Application (2018-2034)
5.2 Global Anti-Emetic Drug Revenue by Application (2018-2034)
5.2.1 Global Anti-Emetic Drug Revenue by Application (2018-2024)
5.2.2 Global Anti-Emetic Drug Revenue by Application (2024-2034)
5.2.3 Global Anti-Emetic Drug Revenue Market Share by Application (2018-2034)
5.3 Global Anti-Emetic Drug Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Anti-Emetic Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novartis Anti-Emetic Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Glenmark Pharmaceuticals Anti-Emetic Drug Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 F. Hoffmann-La Roche Anti-Emetic Drug Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description and Business Overview
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Heron Therapeutics Anti-Emetic Drug Product Portfolio
6.5.5 Heron Therapeutics Recent Developments/Updates
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description and Business Overview
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Kyowa Kirin Anti-Emetic Drug Product Portfolio
6.6.5 Kyowa Kirin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aurobindo Pharma Anti-Emetic Drug Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Mylan Anti-Emetic Drug Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hikma Anti-Emetic Drug Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Akorn Anti-Emetic Drug Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Dr. Reddy’s Laboratories
6.11.1 Dr. Reddy’s Laboratories Corporation Information
6.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Description and Business Overview
6.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Dr. Reddy’s Laboratories Anti-Emetic Drug Product Portfolio
6.11.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Cipla Anti-Emetic Drug Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Fresenius Kabi Anti-Emetic Drug Product Portfolio
6.13.5 Fresenius Kabi Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Wockhardt Anti-Emetic Drug Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Sun Pharmaceutical Industries Anti-Emetic Drug Product Portfolio
6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Teva Pharmaceutical Anti-Emetic Drug Product Portfolio
6.16.5 Teva Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Pfizer Anti-Emetic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Emetic Drug Industry Chain Analysis
7.2 Anti-Emetic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Emetic Drug Production Mode & Process
7.4 Anti-Emetic Drug Sales and Marketing
7.4.1 Anti-Emetic Drug Sales Channels
7.4.2 Anti-Emetic Drug Distributors
7.5 Anti-Emetic Drug Customers
8 Anti-Emetic Drug Market Dynamics
8.1 Anti-Emetic Drug Industry Trends
8.2 Anti-Emetic Drug Market Drivers
8.3 Anti-Emetic Drug Market Challenges
8.4 Anti-Emetic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Emetic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-Emetic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-Emetic Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-Emetic Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Anti-Emetic Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Anti-Emetic Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Anti-Emetic Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Anti-Emetic Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Anti-Emetic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Emetic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Emetic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Emetic Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Emetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Anti-Emetic Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Anti-Emetic Drug Sales Market Share by Region (2018-2024)
Table 19. Global Anti-Emetic Drug Sales by Region (2024-2034) & (K Units)
Table 20. Global Anti-Emetic Drug Sales Market Share by Region (2024-2034)
Table 21. Global Anti-Emetic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Anti-Emetic Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Anti-Emetic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Anti-Emetic Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Anti-Emetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Anti-Emetic Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Anti-Emetic Drug Sales by Country (2024-2034) & (K Units)
Table 28. North America Anti-Emetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Anti-Emetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Anti-Emetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Anti-Emetic Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Anti-Emetic Drug Sales by Country (2024-2034) & (K Units)
Table 33. Europe Anti-Emetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Anti-Emetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Anti-Emetic Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Anti-Emetic Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Anti-Emetic Drug Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Anti-Emetic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Emetic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-Emetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Anti-Emetic Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Anti-Emetic Drug Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Anti-Emetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Anti-Emetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anti-Emetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Anti-Emetic Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Anti-Emetic Drug Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Anti-Emetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Emetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Anti-Emetic Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Anti-Emetic Drug Sales (K Units) by Type (2024-2034)
Table 52. Global Anti-Emetic Drug Sales Market Share by Type (2018-2024)
Table 53. Global Anti-Emetic Drug Sales Market Share by Type (2024-2034)
Table 54. Global Anti-Emetic Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Anti-Emetic Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Anti-Emetic Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Anti-Emetic Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Anti-Emetic Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global Anti-Emetic Drug Price (US$/Unit) by Type (2024-2034)
Table 60. Global Anti-Emetic Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Anti-Emetic Drug Sales (K Units) by Application (2024-2034)
Table 62. Global Anti-Emetic Drug Sales Market Share by Application (2018-2024)
Table 63. Global Anti-Emetic Drug Sales Market Share by Application (2024-2034)
Table 64. Global Anti-Emetic Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Anti-Emetic Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Anti-Emetic Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Anti-Emetic Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Anti-Emetic Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global Anti-Emetic Drug Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck Anti-Emetic Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Novartis Anti-Emetic Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Glenmark Pharmaceuticals Corporation Information
Table 81. Glenmark Pharmaceuticals Description and Business Overview
Table 82. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Glenmark Pharmaceuticals Anti-Emetic Drug Product
Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
Table 85. F. Hoffmann-La Roche Corporation Information
Table 86. F. Hoffmann-La Roche Description and Business Overview
Table 87. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. F. Hoffmann-La Roche Anti-Emetic Drug Product
Table 89. F. Hoffmann-La Roche Recent Developments/Updates
Table 90. Heron Therapeutics Corporation Information
Table 91. Heron Therapeutics Description and Business Overview
Table 92. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Heron Therapeutics Anti-Emetic Drug Product
Table 94. Heron Therapeutics Recent Developments/Updates
Table 95. Kyowa Kirin Corporation Information
Table 96. Kyowa Kirin Description and Business Overview
Table 97. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Kyowa Kirin Anti-Emetic Drug Product
Table 99. Kyowa Kirin Recent Developments/Updates
Table 100. Aurobindo Pharma Corporation Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Aurobindo Pharma Anti-Emetic Drug Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Mylan Anti-Emetic Drug Product
Table 109. Mylan Recent Developments/Updates
Table 110. Hikma Corporation Information
Table 111. Hikma Description and Business Overview
Table 112. Hikma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Hikma Anti-Emetic Drug Product
Table 114. Hikma Recent Developments/Updates
Table 115. Akorn Corporation Information
Table 116. Akorn Description and Business Overview
Table 117. Akorn Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Akorn Anti-Emetic Drug Product
Table 119. Akorn Recent Developments/Updates
Table 120. Dr. Reddy’s Laboratories Corporation Information
Table 121. Dr. Reddy’s Laboratories Description and Business Overview
Table 122. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Dr. Reddy’s Laboratories Anti-Emetic Drug Product
Table 124. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Cipla Anti-Emetic Drug Product
Table 129. Cipla Recent Developments/Updates
Table 130. Fresenius Kabi Corporation Information
Table 131. Fresenius Kabi Description and Business Overview
Table 132. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Fresenius Kabi Anti-Emetic Drug Product
Table 134. Fresenius Kabi Recent Developments/Updates
Table 135. Wockhardt Corporation Information
Table 136. Wockhardt Description and Business Overview
Table 137. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Wockhardt Anti-Emetic Drug Product
Table 139. Wockhardt Recent Developments/Updates
Table 140. Sun Pharmaceutical Industries Corporation Information
Table 141. Sun Pharmaceutical Industries Description and Business Overview
Table 142. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Sun Pharmaceutical Industries Anti-Emetic Drug Product
Table 144. Sun Pharmaceutical Industries Recent Developments/Updates
Table 145. Teva Pharmaceutical Corporation Information
Table 146. Teva Pharmaceutical Description and Business Overview
Table 147. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Teva Pharmaceutical Anti-Emetic Drug Product
Table 149. Teva Pharmaceutical Recent Developments/Updates
Table 150. Pfizer Corporation Information
Table 151. Pfizer Description and Business Overview
Table 152. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Pfizer Anti-Emetic Drug Product
Table 154. Pfizer Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anti-Emetic Drug Distributors List
Table 158. Anti-Emetic Drug Customers List
Table 159. Anti-Emetic Drug Market Trends
Table 160. Anti-Emetic Drug Market Drivers
Table 161. Anti-Emetic Drug Market Challenges
Table 162. Anti-Emetic Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Emetic Drug
Figure 2. Global Anti-Emetic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-Emetic Drug Market Share by Type in 2022 & 2034
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-Emetic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Anti-Emetic Drug Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Care
Figure 12. Others
Figure 13. Global Anti-Emetic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Anti-Emetic Drug Market Size (2018-2034) & (US$ Million)
Figure 15. Global Anti-Emetic Drug Sales (2018-2034) & (K Units)
Figure 16. Global Anti-Emetic Drug Average Price (US$/Unit) & (2018-2034)
Figure 17. Anti-Emetic Drug Report Years Considered
Figure 18. Anti-Emetic Drug Sales Share by Manufacturers in 2022
Figure 19. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Anti-Emetic Drug Players: Market Share by Revenue in 2022
Figure 21. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Anti-Emetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 23. North America Anti-Emetic Drug Sales Market Share by Country (2018-2034)
Figure 24. North America Anti-Emetic Drug Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Anti-Emetic Drug Sales Market Share by Country (2018-2034)
Figure 28. Europe Anti-Emetic Drug Revenue Market Share by Country (2018-2034)
Figure 29. Germany Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2018-2034)
Figure 36. China Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Anti-Emetic Drug Sales Market Share by Country (2018-2034)
Figure 47. Latin America Anti-Emetic Drug Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. UAE Anti-Emetic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Anti-Emetic Drug by Type (2018-2034)
Figure 57. Global Revenue Market Share of Anti-Emetic Drug by Type (2018-2034)
Figure 58. Global Anti-Emetic Drug Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Anti-Emetic Drug by Application (2018-2034)
Figure 60. Global Revenue Market Share of Anti-Emetic Drug by Application (2018-2034)
Figure 61. Global Anti-Emetic Drug Price (US$/Unit) by Application (2018-2034)
Figure 62. Anti-Emetic Drug Value Chain
Figure 63. Anti-Emetic Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed